Title : Efficacy of biological therapies and small molecules in moderate to severe ulcerative colitis: systematic review and network meta-analysis.

Pub. Date : 2021 Dec 22

PMID : 34937767






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Upadacitinib ranked first for clinical remission in both patients naive to anti-TNF-alpha drugs (RR 0.69; 95% CI 0.61 to 0.78, P-score 0.99) and previously exposed (RR 0.78; 95% CI 0.72 to 0.85, P-score 0.99). upadacitinib tumor necrosis factor Homo sapiens
2 CONCLUSION: In a network meta-analysis, upadacitinib 45 mg once daily ranked first for clinical remission in all patients, patients naive to anti-TNF-alpha drugs and patients previously exposed. upadacitinib tumor necrosis factor Homo sapiens